Molecular docking studies on the interaction of NCI anticancer analogues with human Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit
Volume 31 | Issue 4 | October 2019
Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.